Allspring Global Investments Holdings, LLC Intra Cellular Therapies, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $62.1 Billion
- Q3 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 1,855 shares of ITCI stock, worth $175,983. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,855
Previous 69,696
97.34%
Holding current value
$175,983
Previous $4.77 Million
97.17%
% of portfolio
0.0%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding ITCI
# of Institutions
379Shares Held
84.1MCall Options Held
319KPut Options Held
143K-
Vanguard Group Inc Valley Forge, PA9.63MShares$913 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$600 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.29MShares$502 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.85MShares$365 Million1.4% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.05MShares$289 Million3.36% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $8.96B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...